Gene expression profile of chronic myeloid leukemia innately resistant to imatinib
G Cammarata, L Augugliaro, M La Rosa, D Turri… - Clinical Leukemia, 2007 - Elsevier
Background After 12 months of treatment, most patients with chronic myeloid leukemia
(CML) who receive imatinib as first-line therapy will have complete cytogenetic and …
(CML) who receive imatinib as first-line therapy will have complete cytogenetic and …
c-abl 基因在卵巢恶性肿瘤中的突变及意义
吴春凤， 李萌， 安牧尔 - 哈尔滨医科大学学报, 2008 - cqvip.com
目的研究c-abl 基因在人卵巢肿瘤组织中的突变情况及其临床意义, 探讨其在卵巢肿瘤的发生,
发展过程中的作用. 方法应用PCR 技术及序列分析方法检测和分析88 例正常卵巢 …
发展过程中的作用. 方法应用PCR 技术及序列分析方法检测和分析88 例正常卵巢 …
Novel cellular and molecular interactions during limb development, revealed from studies on the split hand foot congenital malformation
D Conte, L Guerrini, GR Merlo - New Discoveries in Embryology, 2015 - books.google.com
The embryonic development of the limbs is widely used as a paradigm for the
comprehension of the cellular processes and molecular mechanisms underlying …
comprehension of the cellular processes and molecular mechanisms underlying …
[PDF][PDF] Patogeneza przewlekłej białaczki szpikowej-od genu do terapii celowanej
J Żołnierowicz, J Kawiak, G Hoser - Hematologia, 2010 - core.ac.uk
Rozwój przewlekłej białaczki szpikowej (CML) jest związany z pojawieniem się wzajemnej
translokacji chromosomalnej (9; 22)(q34; q11). W wyniku wymiany fragmentów …
translokacji chromosomalnej (9; 22)(q34; q11). W wyniku wymiany fragmentów …
[图书][B] A Comprehensive Approach to Understanding p66Shc Mitochondrial Function in Cardiovascular Health
LH Haslem - 2022 - search.proquest.com
Abstract p66Shc governs outcomes for many pathologies, including endothelial dysfunction,
coronary artery disease (CAD), and ischemia/reperfusion injuries (IRI). During …
coronary artery disease (CAD), and ischemia/reperfusion injuries (IRI). During …
[HTML][HTML] Detection of ABL1 deletion without BCR-ABL rearrangement in ETP-ALL
A Makboul, WT El-Mahdy, DF Temerik - Hematology, Transfusion and Cell …, 2022 - Elsevier
Acute lymphoblastic leukemia (ALL) is characterized by proliferation of blasts that are
committed to B cell or T cell lineage. 1 A particular challenging subtype is early T cell …
committed to B cell or T cell lineage. 1 A particular challenging subtype is early T cell …
Targeting the p53/MDM2 protein-protein interaction
SA Goffin - 2016 - ueaeprints.uea.ac.uk
The p53/MDM2 protein-protein interaction is the most widely characterised proteinprotein
interaction to date. As of 2014, there are over 20 compounds that have been shown to the …
interaction to date. As of 2014, there are over 20 compounds that have been shown to the …
Human Papilloma Virus, Epstein-Barr Virus, and Herpes Simplex Virus Type-1 in Oral Squamous Cell Carcinomas from Three Populations
J Jalouli - 2010 - diva-portal.org
AIDS Acquired immunodeficiency syndrome BL Burkitt's lymphoma bp Base pair CMV
Cytomegalovirus DNA Deoxyribonucleic acid EBV Epstein-Barr virus GMK Green monkey …
Cytomegalovirus DNA Deoxyribonucleic acid EBV Epstein-Barr virus GMK Green monkey …
Pathogenesis of chronic myeloid leukemia-from gene to targeted therapy
J Żołnierowicz, J Kawiak… - Hematology in Clinical …, 2010 - journals.viamedica.pl
The occurrence of chronic myeloid leukemia (CML) is related to the appearance of
reciprocal chromosomal translocation (9; 22)(q34; q11). As a result of translocation between …
reciprocal chromosomal translocation (9; 22)(q34; q11). As a result of translocation between …
[PDF][PDF] Hematology, Transfusion and Cell Therapy
A Makboul, WT El-Mahdy, DF Temerik - researchgate.net
Acute lymphoblastic leukemia (ALL) is characterized by proliferation of blasts that are
committed to B cell or T cell lineage. 1 A particular challenging subtype is early T cell …
committed to B cell or T cell lineage. 1 A particular challenging subtype is early T cell …